Sugammadex Sodium contains not less than 95.0% and not more than 102.0% of C72H104Na8O48S8, calculated on anhydrous and solvent free basis.

共有 1 個藥物證書使用此成份

γ-環糊精硫丙酸鈉鹽
Sugammadex Sodium

申請商
新雙隆生技股份有限公司 
適應症
拮抗rocuronium或vecuronium誘導的神經肌肉阻斷
含量
發證日期
2023-05-23